Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $566.9900 (-2.41%) ($565.7500 - $583.3750) on Tue. Aug. 11, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 12.54% (three month average) | | RSI | 55 | | Latest Price | $566.9900(-2.41%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | | Weekly Trend | REGN advances 2.9% a week on average for past two weeks. | | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(66%) XLV(53%) XBI(50%) QQQ(43%) SPY(42%) | | Factors Impacting REGN price | REGN will decline at least -6.27% in a week (0% probabilities).
VIXM(-17%) TLT(-10%) SHY(-5%) UUP(-4%) TIP(-3%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -6.27% (StdDev 12.54%) | | Hourly BBV | 0 () | | Intraday Trend | -1.9% | | | | | |
|
| 5 Day Moving Average | $580.38(-2.31%) | | 10 Day Moving Average | $569.12(-0.37%) | | 20 Day Moving Average | $560.61(1.14%) | | To recent high | -4.3% | | To recent low | 18.8% | | Market Cap | $60.117b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |